Udar mózgu
Epidemiologia

Udar mózgu pozostaje jednym z najważniejszych wyzwań zdrowia publicznego na świecie, będąc drugą najczęstszą przyczyną zgonów i trzecią przyczyną niepełnosprawności. Rocznie na świecie dochodzi do około 12,2 miliona nowych przypadków udaru, z czego ponad 6,5 miliona kończy się śmiercią. W 2021 roku udar stanowił 10,7% wszystkich zgonów globalnie. Epidemiologia udaru wykazuje wyraźne różnice geograficzne i demograficzne – w krajach o wysokim dochodzie obserwuje się stabilizację lub spadek zapadalności, natomiast w krajach o niskim i średnim dochodzie wskaźniki te rosną. W USA udar jest czwartą przyczyną zgonów, a jego koszty opieki medycznej sięgają 68,9 miliarda dolarów (dane z 2009 roku). Dominującym typem udaru są udary niedokrwienne (87%), z globalną zapadalnością na poziomie 7,59 miliona przypadków w 2020 roku. Najważniejszymi modyfikowalnymi czynnikami ryzyka są nadciśnienie tętnicze, palenie tytoniu, otyłość, cukrzyca oraz dyslipidemia, które odpowiadają za około 90% wszystkich udarów według badania INTERSTROKE (2016). Wiek pozostaje najsilniejszym niemodyfikowalnym czynnikiem ryzyka, z gwałtownym wzrostem zapadalności po 55. roku życia.

Epidemiologia udaru mózgu – perspektywa globalna

Udar mózgu stanowi jeden z najpoważniejszych problemów zdrowia publicznego na świecie, będąc drugą najczęstszą przyczyną śmierci i trzecią wiodącą przyczyną niepełnosprawności w skali globalnej. Według Światowej Organizacji Zdrowia (WHO), każdego roku około 15 milionów ludzi doświadcza udaru mózgu, z czego około 5 milionów umiera, a kolejne 5 milionów pozostaje trwale niepełnosprawnymi.12 W 2021 roku udar mózgu był trzecią najczęstszą przyczyną zgonów na poziomie 3 klasyfikacji GBD (Global Burden of Disease), po chorobie niedokrwiennej serca i COVID-19, stanowiąc 10,7% wszystkich zgonów.3

Najnowsze dane z badania Global Burden of Disease wskazują, że w 2020 roku około 12,2 miliona osób na całym świecie doświadczyło nowego udaru mózgu, a liczba zgonów z tego powodu wyniosła ponad 6,5 miliona rocznie. Ryzyko wystąpienia udaru mózgu w ciągu życia szacuje się na 1 na 4 osoby powyżej 25 roku życia, co podkreśla powszechność tego schorzenia.45 W Stanach Zjednoczonych udar mózgu jest czwartą przyczyną zgonów i główną przyczyną niepełnosprawności u dorosłych, z szacowanymi bezpośrednimi i pośrednimi kosztami opieki w wysokości 68,9 miliarda dolarów w 2009 roku.6

Trendy geograficzne i demograficzne

Obciążenie udarem mózgu wykazuje znaczące różnice geograficzne i demograficzne. Podczas gdy w krajach o wysokim dochodzie obserwuje się tendencję spadkową lub stabilizację wskaźników zapadalności i śmiertelności, w krajach o niskim i średnim dochodzie sytuacja jest odwrotna.78 W ostatnich dekadach, dzięki lepszej kontroli czynników ryzyka naczyniowego, wskaźniki zachorowalności na udar w krajach rozwiniętych uległy niewielkiemu zmniejszeniu lub stabilizacji. Jednak ze względu na starzenie się populacji, szczególnie w krajach zachodnich, przewiduje się, że wskaźniki te dramatycznie wzrosną w ciągu najbliższych 40 lat.9

W Stanach Zjednoczonych częstość występowania udaru wzrosła o 7,8% w latach 2011-2013 do 2020-2022. Wzrost ten zaobserwowano u dorosłych w wieku 18-64 lat, zarówno kobiet jak i mężczyzn, osób rasy czarnej lub Afroamerykanów, białych nie-Latynosów oraz dorosłych Latynosów, a także u osób z wykształceniem niższym niż wyższe. Występowanie udaru było wyższe wśród osób w wieku 65 lat i starszych, rdzennych Amerykanów lub rdzennych mieszkańców Alaski, rdzennych Hawajczyków lub mieszkańców Wysp Pacyfiku oraz osób rasy czarnej, a także dorosłych o niższym poziomie wykształcenia.10

Największe wskaźniki obciążenia udarem obserwuje się w krajach o niskim dochodzie. Aby przeciwdziałać wzrostowi częstości występowania udaru na całym świecie, potrzebne są skuteczne strategie profilaktyki pierwotnej.11 Ryzyko wystąpienia pierwszego udaru jest prawie dwukrotnie wyższe u dorosłych nie-Latynosów rasy czarnej niż u osób białej, a najwyższe wskaźniki zgonów z powodu udaru mają dorośli rasy czarnej oraz mieszkańcy Wysp Pacyfiku.12

Typy udaru i ich rozpowszechnienie

Udary dzielą się na dwa główne typy: niedokrwienne i krwotoczne. Około 87% wszystkich udarów stanowią udary niedokrwienne, w których przepływ krwi do mózgu jest zablokowany.13 Według danych z Global Burden of Disease, w 2020 roku globalny wskaźnik zapadalności na wszystkie typy udarów wynosił 11,71 miliona osób, z czego 7,59 miliona przypadało na udary niedokrwienne, 3,41 miliona na krwotoki śródmózgowe i 0,71 miliona na krwotoki podpajęczynówkowe.14

W Turcji w 2019 roku zapadalność na udar wynosiła 125 345 przypadków (154 na 100 tysięcy), a chorobowość 1 080 380 (1,3%). Udary niedokrwienne stanowiły 65,1% wszystkich udarów, krwotoki śródmózgowe 24%, a krwotoki podpajęczynówkowe 10,9%. Chociaż obserwuje się liczbowy wzrost wszystkich typów udarów wraz ze starzeniem się populacji, wzrost częstości występowania udarów krwotocznych jest ograniczony w czasie, gdy przeprowadza się standaryzację częstości według wieku.15

Czynniki ryzyka udaru mózgu

Czynniki ryzyka udaru mózgu można ogólnie podzielić na modyfikowalne i niemodyfikowalne. Identyfikacja i zrozumienie czynników demograficznych związanych z udarem oraz dysproporcji w jego występowaniu może pomóc w ukierunkowaniu interwencji programowych i klinicznych w celu poprawy zapobiegania i leczenia udaru na poziomie stanowym i krajowym.16

Czynniki niemodyfikowalne

Wiek jest najsilniejszym niemodyfikowalnym czynnikiem ryzyka udaru, a u starszych pacjentów z udarem zazwyczaj występują wyższe wskaźniki śmiertelności i zmniejszona zdolność do funkcjonalnego powrotu do zdrowia.17 Zapadalność na udar gwałtownie wzrasta z wiekiem, podwajając się dla każdej dekady po 55 roku życia.18 Chociaż udar jest często uważany za chorobę osób starszych, jedna trzecia udarów występuje u osób poniżej 65 roku życia. Ryzyko udaru wzrasta z wiekiem, szczególnie u pacjentów powyżej 64 roku życia, u których występuje 75% wszystkich udarów.19

Historycznie udokumentowano, że częstość występowania udaru jest wyższa u mężczyzn niż u kobiet. Jednak najnowsze badania wykazały, że występuje spadek liczby udarów niedokrwiennych wśród mężczyzn, co oznacza, że częstość występowania udaru maleje bardziej u mężczyzn niż u kobiet, a ogólna częstość występowania udaru z czasem maleje.20 W Stanach Zjednoczonych mężczyźni są narażeni na większe ryzyko udaru niż kobiety; biali mężczyźni mają zapadalność na udar 62,8 na 100 000, przy czym śmierć jest ostatecznym wynikiem w 26,3% przypadków, podczas gdy kobiety mają zapadalność na udar 59 na 100 000 i wskaźnik śmiertelności 39,2%.21

Czynniki modyfikowalne

Najważniejszymi modyfikowalnymi czynnikami ryzyka udaru są wysokie ciśnienie krwi, wysoki cholesterol, palenie tytoniu, otyłość i cukrzyca.22 Nadciśnienie tętnicze jest najważniejszym modyfikowalnym czynnikiem ryzyka wystąpienia udaru, jednak wynik udaru nie był znacząco zależny od obecności nadciśnienia, ponieważ liczba pacjentów z nadciśnieniem z korzystnymi wynikami i tych ze zwiększoną zachorowalnością i śmiertelnością była podobna.23

Wysokie ciśnienie krwi i używanie tytoniu są najbardziej znaczącymi modyfikowalnymi czynnikami ryzyka. Na każde 10 osób, które umierają z powodu udaru, cztery można by było uratować, gdyby ich ciśnienie krwi było uregulowane. Wśród osób w wieku poniżej 65 lat, dwie piąte zgonów z powodu udaru jest związanych z paleniem tytoniu. Migotanie przedsionków, niewydolność serca i zawał serca to inne ważne czynniki ryzyka.24

Niedawne badanie INTERSTROKE z 2016 roku analizowało potencjalne skutki modyfikowalnych czynników ryzyka związanych z udarem w 32 krajach. Wśród 13 000 przypadków udaru wykazano, że modyfikowalne czynniki ryzyka, takie jak dieta, brak aktywności fizycznej, nadciśnienie tętnicze, czynniki psychospołeczne, przyczyny kardiologiczne, cukrzyca, palenie tytoniu, otyłość brzuszna, hiperlipidemia i spożywanie alkoholu, odpowiadały za około 90% wszystkich udarów.25

Nadzór epidemiologiczny i systemy monitorowania udaru

Nadzór nad udarem stanowi ważny element ogólnej kontroli udaru, ponieważ dostarcza informacji na temat etiologii, ryzyka, rokowania, zapobiegania i interwencji, a także rozkładu choroby i trendów czasowych.26 WHO zaproponowała system nadzoru nad udarem obejmujący trzy etapy, które reprezentują możliwe początkowe wyniki dla pacjentów z udarem: zdarzenia w szpitalu, zdarzenia śmiertelne w społeczności i zdarzenia niepowodujące zgonu w społeczności.27

Podejście WHO do nadzoru nad udarem zapewnia elastyczny system i daje wszystkim krajom możliwość przyczynienia się do gromadzenia danych na temat udaru. Stopniowe podejście WHO do nadzoru nad udarem obejmuje kilka etapów, które pozwalają na kompleksowe monitorowanie tej choroby.28 Badanie WHO STEPS dotyczące nadzoru nad udarem koncentruje się na pacjentach hospitalizowanych z powodu udaru (STEP-1) i dostarcza ramy do badania pacjentów z udarem.29

Programy nadzoru i inicjatywy krajowe

Centrum Kontroli i Zapobiegania Chorobom (CDC) oraz jego partnerzy prowadzą krajowe inicjatywy i programy mające na celu zmniejszenie wskaźników śmierci i niepełnosprawności spowodowanych udarem oraz pomoc ludziom w dłuższym, zdrowszym życiu. Przykładem jest Paul Coverdell National Acute Stroke Program, który finansuje stany w celu mierzenia, śledzenia i poprawy jakości opieki nad pacjentami z udarem. Program ten pracuje nad zmniejszeniem śmierci i niepełnosprawności spowodowanych udarem.30

W Chinach, z uwagi na wysokie obciążenie udarem, utworzono Bigdata Observatory Platform for Stroke of China (BOSC), który gromadzi i analizuje dane dotyczące udaru z wielu szpitali w całym kraju. W 2020 roku platforma ta zebrała dane dotyczące 3 418 432 przypadków udaru przyjętych do 1599 szpitali.31 Raport China Stroke Surveillance Report 2021 koncentruje się na postępach w diagnostyce i leczeniu udaru, rozwoju chińskiego systemu zapobiegania i kontroli udaru, budowie platformy BOSC, analizie danych z projektów badań przesiewowych i interwencji dla grup wysokiego ryzyka udaru oraz perspektywach zapobiegania i leczenia udaru.32

W Stanach Zjednoczonych brakuje systemu nadzoru nad udarem. W związku z tym prowadzone są badania nad metodami przekształcania istniejących rejestrów w reprezentatywne krajowo bazy danych do oceny jakości opieki w ostrym udarze niedokrwiennym. Wykorzystanie istniejących baz danych z rejestrami pacjentów do opracowania wag post-stratyfikacyjnych jest wiarygodnym podejściem do oszacowania epidemiologii ostrego udaru niedokrwiennego i monitorowania jakości opieki w skali krajowej.33

Znaczenie nadzoru epidemiologicznego

Dokładne informacje na temat zachorowalności na powikłania neurologiczne i czasu oceny wzrokowej są ważne przy rozważaniu potrzeb osób, które przeżyły udar, i rozwijaniu usług dla odpowiedniej i adekwatnej opieki nad pacjentem. W badaniu przeprowadzonym w Wielkiej Brytanii wykazano, że częstość występowania nowych problemów wzrokowych z powodu udaru wynosiła 48% dla wszystkich przyjęć z powodu udaru i 60% u osób, które przeżyły udar. Trzy czwarte (73%) miało problemy ze wzrokiem: 56% z upośledzeniem widzenia centralnego, 40% z nieprawidłowościami ruchów gałek ocznych, 28% z utratą pola widzenia, 27% z nieuwagą wzrokową, 5% z zaburzeniami percepcji wzrokowej.3435

Śledzenie zdrowia publicznego w zakresie chorób serca i udaru jest istotną częścią zmniejszania obciążenia chorobą, identyfikowania grup wysokiego ryzyka, formułowania polityki opieki zdrowotnej i oceny postępów w zapobieganiu tej chorobie. Przykładem jest Connecticut Heart Disease Stroke Surveillance System (CHDSS), którego celem jest dostarczanie aktualnych i istotnych informacji o chorobach serca, udarze i ich powikłaniach w Connecticut, a także informacji o powiązanych czynnikach ryzyka.36

Obciążenie ekonomiczne i społeczne udaru

Udar stanowi ogromne obciążenie dla zdrowia publicznego, które ma wzrosnąć w nadchodzących dekadach ze względu na przemiany demograficzne populacji, szczególnie w krajach rozwijających się.37 Jest to choroba o ogromnym znaczeniu dla zdrowia publicznego, o poważnych konsekwencjach ekonomicznych i społecznych.38

Koszty ekonomiczne

Udar nakłada znaczne obciążenie ekonomiczne na systemy opieki zdrowotnej. W samych Stanach Zjednoczonych roczne bezpośrednie i pośrednie koszty udaru szacuje się na ponad 50 miliardów dolarów.39 Według danych z lat 2019-2020, koszty związane z udarem w Stanach Zjednoczonych wyniosły prawie 56,2 miliarda dolarów.40

Szacunki sugerują, że udar pochłania 24% całkowitych kosztów opieki zdrowotnej na całym świecie. W krajach rozwiniętych odsetek ten przekracza 4% kosztów opieki zdrowotnej. W Stanach Zjednoczonych szacowany koszt udaru w 2008 roku wyniósł 34,3 miliarda dolarów, w tym bezpośrednie koszty medyczne w wysokości 18,8 miliarda dolarów.41

Globalny wpływ ekonomiczny udaru obecnie stanowi 0,66% globalnego PKB, a całkowity koszt udaru ma osiągnąć 1 bilion dolarów amerykańskich do 2030 roku.42 Zrozumienie epidemiologii udaru jest niezbędne do opracowania skutecznych strategii zapobiegania, leczenia i rehabilitacji.43

Wpływ społeczny i niepełnosprawność

Udar jest wiodącą przyczyną poważnej długotrwałej niepełnosprawności. Zmniejsza mobilność u ponad połowy osób, które przeżyły udar w wieku 65 lat i starszych.44 Udar potencjalnie stanowi najbardziej niszczycielski skutek choroby naczyniowej, powodując długotrwałą niepełnosprawność i nakładając wysokie obciążenia medyczne, emocjonalne i finansowe na pacjenta.45

W Stanach Zjednoczonych każdego roku ponad 795 000 osób doświadcza udaru. Około 610 000 z nich to pierwsze lub nowe udary, a około 185 000 udarów, prawie 1 na 4, występuje u osób, które miały już wcześniej udar.46

Wynik udaru zależy zasadniczo od rodzaju udaru, jego ciężkości i podtypu. Jednak zachorowalność i śmiertelność z powodu udaru, określone przez wynik po 4 tygodniach za pomocą skali MRS, są znacznie wyższe u pacjentów w podeszłym wieku z cukrzycą i chorobą niedokrwienną serca oraz u palaczy.47

Znaczenie profilaktyki i wczesnej interwencji

Epidemiologiczne badania udaru pomagają nam zrozumieć naturalną historię choroby, identyfikację czynników ryzyka i czynników prognostycznych, które mogą prowadzić do markerów mechanizmów choroby. Dane epidemiologiczne i obserwacyjne mogą informować naukowców o możliwych nowych obszarach do bardziej ukierunkowanych badań.48

Strategie profilaktyki pierwotnej

Profilaktyka pierwotna udaru jest niezbędna do utrzymania zdrowia mózgu przez całe życie. Przestrzeganie zdrowego stylu życia i rutynowe badania przesiewowe w kierunku czynników ryzyka udaru mogą promować zdrowe starzenie się bez udaru.49 Zmiana czynników ryzyka odgrywa dużą rolę w zapobieganiu udarowi. Strategie wczesnej interwencji, szczególnie w przypadku nadciśnienia tętniczego, mają kluczowe znaczenie dla zmniejszenia zachorowalności i śmiertelności z powodu udaru.50

Zwiększona świadomość społeczeństwa na temat czynników ryzyka i ich zarządzania nie tylko pomaga w pierwotnej profilaktyce udaru, ale także prowadzi do wczesnego leczenia i lepszych wyników udaru.51 Skuteczne programy krajowe, takie jak inicjatywa Million Hearts 2027, utrzymują repozytorium zrównoważonych interwencji koncentrujących się na zapobieganiu czynnikom ryzyka udaru i poprawie zarządzania klinicznego, które można powielać w różnych społecznościach.52

Dostęp do opieki i leczenie

Dostępność opieki medycznej dla udaru ma ogromne znaczenie. Jak wykazała analiza wskaźnika przeżywalności, średni czas przeżycia zależy bezpośrednio od stanu pacjenta przy przyjęciu do szpitala. Wskaźnik przeżywalności pacjentów z różnymi nozologiami krążenia mózgowego u mężczyzn i kobiet różni się znacznie i osiąga 80 lat.53 Właściwa organizacja zarządzania opieką medyczną dla pacjentów z ostrymi zaburzeniami krążenia ma pierwszorzędne znaczenie. Konieczne jest wzmocnienie integracji i koordynacji systemów opieki w nagłych wypadkach i podstawowej opieki zdrowotnej.54

Chociaż znany był fakt, że częstość występowania udaru była wysoka, badania wskazują, że udary w niektórych regionach dotykają młodszych pacjentów i więcej mężczyzn niż w innych obszarach geograficznych. Porównania wyników pokazują, że pacjenci z udarem w niektórych regionach są epidemiologicznie nietypowi, ponieważ są młodsi i częściej są mężczyznami niż pacjenci w innych regionach. Czynniki ryzyka udaru i opóźnienie między udarem a przyjęciem do szpitala są porównywalne z tym, co obserwuje się w innych krajach, co sugeruje, że wysiłki powinny koncentrować się na podstawowej opiece i społecznych nierównościach zdrowotnych w celu złagodzenia głównych determinantów udaru.5556

Trendy i przyszłe kierunki w epidemiologii udaru

W ciągu ostatnich 30 lat łączna zapadalność na wszystkie udary krwotoczne i niedokrwienne wzrosła o 117% z dość stabilnym przyspieszeniem, zwiększając się z 57 650 (97 na 100 000) do 125 235 (154 na 100 000).57 Chociaż liczba bezwzględna udarów wzrosła o 70% od 1990 roku, prawdopodobnie z powodu wzrostu liczby ludności na świecie, zapadalność zmniejszyła się o 17% między 1990 a 2019 rokiem, prawdopodobnie z powodu zmniejszonej częstości występowania czynników ryzyka udaru, takich jak nadciśnienie tętnicze i cukrzyca.58

Różnice demograficzne i geograficzne w trendach

W badaniach epidemiologicznych przeprowadzonych w ostatniej dekadzie zarówno w Europie, jak i Ameryce Północnej zaobserwowano znaczący wzrost częstości występowania udaru niedokrwiennego wśród młodych pacjentów. Tendencja ta była również widoczna w badanym okresie. U młodych dorosłych, którzy doświadczyli udaru niedokrwiennego, stwierdzono wyższe wskaźniki naczyniowych czynników ryzyka w porównaniu z populacją ogólną.59

Globalny rozkład udaru podkreśla znaczące różnice między krajami o wysokim i niskim dochodzie. W krajach o wysokim dochodzie (HIC) infrastruktura opieki zdrowotnej, wczesne wykrywanie i środki zapobiegawcze doprowadziły do spadku wskaźników śmiertelności z powodu udaru. Natomiast kraje o niskim i średnim dochodzie (LMIC) stoją w obliczu rosnącego obciążenia udarem z powodu ograniczonych zasobów, braku świadomości i nieodpowiedniego dostępu do opieki zdrowotnej.60

Stwierdzono, że częstość występowania zakrzepicy związanej z rakiem wzrasta z czasem, przy czym najwyższe wskaźniki występują w raku trzustki, mózgu, płuc i jajnika, a najniższe w raku prostaty i piersi. Ryzyko udaru u pacjentów z rakiem jest najwyższe wśród pacjentów z przerzutami odległymi i w ciągu sześciu miesięcy od diagnozy. Ryzyko udaru wydaje się korelować z agresywnością samego raka, ponieważ przerzutowy rak płuc, trzustki i jelita grubego wydaje się nieść najwyższe ryzyko.61

Wyzwania i kierunki przyszłych badań

Obciążenie udarem wzrosło od 1990 do 2021 roku, a udział kilku czynników ryzyka również wzrósł. Skuteczne, dostępne i przystępne cenowo środki mające na celu poprawę nadzoru nad udarem, zapobiegania (z naciskiem na ciśnienie krwi, styl życia i czynniki środowiskowe), ostrej opieki i rehabilitacji muszą być pilnie wdrożone we wszystkich krajach w celu zmniejszenia obciążenia udarem.62

Stwierdzono rozbieżności w obciążeniu udarem i czynnikach ryzyka według regionu GBD, kraju lub terytorium, a także stagnację w zmniejszaniu zapadalności od 2015 roku, a nawet pewne wzrosty wskaźników zapadalności, śmiertelności, chorobowości i DALYs z powodu udaru w Azji Południowo-Wschodniej, Azji Wschodniej i Oceanii, krajach o niższym SDI oraz osób w wieku poniżej 70 lat.63

Podczas gdy odnotowano spadek częstości występowania udaru i śmiertelności w krajach o wysokim dochodzie, zaobserwowano odwrotną tendencję w krajach o niskim i średnim dochodzie. Chociaż postęp w zapobieganiu i leczeniu udaru doprowadził do wielu sukcesów w walce z tą chorobą w ciągu ostatnich 2 dekad, wiele wyzwań pozostaje, ponieważ klinicyści i badacze nadal próbują odkryć podstawowe przyczyny wielu różnic w obciążeniu udarem i jego wynikach zaobserwowanych w badaniach epidemiologicznych, aby móc opracować interwencje mające na celu poprawę śmiertelności i niepełnosprawności z powodu udaru dla wszystkich.64

Globalne wskaźniki zapadalności na udar mózgu w wybranych krajach (na 100 000 osób rocznie)
Kraj Wskaźnik śmiertelności skorygowany wiekowo
Kanada 25,7
USA 30,4
Australia 32,6
Wielka Brytania 45,6
Kirgistan 249,4
Indie 108
Chiny 156,5
Federacja Rosyjska 228
Republika Południowej Afryki 141,1
Nigeria 152,8
Brazylia 91,1
Pakistan 117,9

65

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #2 WHO EMRO | Stroke, Cerebrovascular accident | Health topics
    https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html
    Stroke carries a high risk of death. Survivors can experience loss of vision and/or speech, paralysis and confusion. Stroke is so called because of the way it strikes people down. The risk of further episodes is significantly increased for people having experienced a previous stroke. The risk of death depends on the type of stroke. Transient ischaemic attacks or TIA where symptoms resolve in less than 24 hours have the best outcome, followed by stroke caused by carotid stenosis (narrowing of the artery in the neck that supplies blood to the brain). Blockage of an artery is more dangerous, with rupture of a cerebral blood vessel the most dangerous of all. […] Annually, 15 million people worldwide suffer a stroke. Of these, 5 million die and another 5 million are left permanently disabled, placing a burden on family and community. Stroke is uncommon in people under 40 years; when it does occur, the main cause is high blood pressure. However, stroke also occurs in about 8% of children with sickle cell disease.
  • #3 Global, regional, and national burden of stroke and its risk factors, 1990–2021 | Institute for Health Metrics and Evaluation
    https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021
    In 2021, stroke was the third most common GBD level 3 cause of death, after ischemic heart disease and COVID-19, constituting 10.7% of all deaths. […] Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning. […] We estimated incidence, prevalence, death, and disability-adjusted life-year (DALY) counts and age-standardised rates per 100000 people per year for overall stroke, ischaemic stroke, intracerebral haemorrhage, and subarachnoid haemorrhage, for 204 countries and territories from 1990 to 2021. […] We found disparities in stroke burden and risk factors by GBD region, country or territory, and SDI, as well as a stagnation in the reduction of incidence from 2015 onwards, and even some increases in the stroke incidence, death, prevalence, and DALY rates in southeast Asia, east Asia, and Oceania, countries with lower SDI, and people younger than 70 years.
  • #4 Epidemiology of Stroke: A Comprehensive Overview
    https://www.openaccessjournals.com/articles/epidemiology-of-stroke-a-comprehensive-overview-18440.html
    Stroke, a leading cause of mortality and long-term disability worldwide, poses a significant public health challenge. […] This article provides a detailed examination of the epidemiology of stroke, including its incidence, prevalence, risk factors, geographic distribution and the impact on healthcare systems. […] Stroke is the second leading cause of death globally, after ischemic heart disease. […] According to the (GBD) study, approximately 12.2 million people experience a new stroke each year, resulting in over 6.5 million deaths annually. […] The lifetime risk of stroke is estimated to be 1 in 4 for individuals over the age of 25, highlighting the widespread nature of this condition. […] The risk factors for stroke can be broadly categorized into modifiable and non-modifiable factors.
  • #5 World Stroke Organization
    https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke
    Stroke is a leading cause of death and disability worldwide. Globally, 1 in 4 adults over the age of 25 will have a stroke in their lifetime. […] Over 12 million people worldwide will have their first stroke this year and 6.5 million will die as a result. Over 100 million people in the world have experienced stroke. The incidence of stroke increases significantly with age, however over 60% of strokes happen to people under the age of 70 and 16% happen to those under the age of 50. […] Rates of stroke are growing fastest in low and middle income countries, often where healthcare providers find it more challenging to provide the care that is needed for effective prevention, treatment and rehabilitation of stroke. […] The global economic impact of stroke currently represents 0.66% of Global GDP and the total cost of stroke is estimated to tip US$1 trillion by 2030.
  • #6 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    Stroke is the fourth killer and number one cause of adult disability in the United States. The estimated direct and indirect costs of stroke care in this country are $68.9 billion for 2009. The prevalence of stroke and its cost will undoubtedly rise as the aging population increases. In addition, stroke incidence and mortality are increasing in less developed countries in which the lifestyles and population restructuring are rapidly changing. More population-based research to assess incidence, risk factors, and outcomes are needed in these countries. Epidemiologic studies can help identify groups of individuals or regions at higher risk for stroke. They can also help us better understand the natural history of certain conditions and therefore push the direction of therapeutic investigations. Furthermore, the study of trends across different time periods and different populations can help investigators evaluate the effects of stroke care programs and treatment options.
  • #7 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    The incidence of stroke rapidly increases with age, doubling for each decade after age 55. […] Perhaps due to better control of vascular risk factors during the last decade, incidence rates of stroke in developed nations have modestly diminished or plateaued. […] It has been projected that with continued aging of the population, especially in Western countries, these rates are expected to rise again dramatically during the next 40 years. […] Understanding the factors that are associated with clinical outcomes can lead to more effective interventions to reduce case fatality and mortality, and to improve functional status in patients with stroke. […] In general, the trends in stroke incidence and mortality rates have decreased in the recent decades for high-income countries such as the U.S., the United Kingdom, and Canada.
  • #8 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    While there have been reports of decreased stroke incidence and mortality in high-income countries, the opposite has been observed in low-to-middle income countries. […] Although advancement in stroke prevention and management has led to many successes in the fight against this disease for the past 2 decades, many challenges remain as clinicians and investigators continue to try and uncover the underlying causes behind the many disparities in stroke burden and outcome observed in epidemiologic studies to be able to design interventions to improve stroke mortality and disability for all.
  • #9 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    The incidence of stroke rapidly increases with age, doubling for each decade after age 55. […] Perhaps due to better control of vascular risk factors during the last decade, incidence rates of stroke in developed nations have modestly diminished or plateaued. […] It has been projected that with continued aging of the population, especially in Western countries, these rates are expected to rise again dramatically during the next 40 years. […] Understanding the factors that are associated with clinical outcomes can lead to more effective interventions to reduce case fatality and mortality, and to improve functional status in patients with stroke. […] In general, the trends in stroke incidence and mortality rates have decreased in the recent decades for high-income countries such as the U.S., the United Kingdom, and Canada.
  • #10 Prevalence of Stroke — Behavioral Risk Factor Surveillance System, United States, 2011–2022 | MMWR
    https://www.cdc.gov/mmwr/volumes/73/wr/mm7320a1.htm
    From 2011-2013 to 2020-2022, U.S. stroke prevalence increased by 7.8%. Increases occurred among adults aged 18-64 years; females and males; non-Hispanic Black or African American (Black), non-Hispanic White, and Hispanic or Latino (Hispanic) adults; and adults with less than a college degree. Stroke prevalence was higher among adults aged 65 years; non-Hispanic American Indian or Alaska Native, non-Hispanic Native Hawaiian or Pacific Islander, and Black adults; and adults with lower education. Stroke prevalence decreased in the District of Columbia and increased in 10 states. […] This analysis found that age-standardized stroke prevalence increased by 7.8% from 2011-2013 to 2020-2022. This increase contrasts with the decrease of 3.7% reported during 2006-2010. Significant increases in stroke prevalence were observed among several sociodemographic groups, including adults aged 18-44 and 45-64 years; females and males; Black, White, and Hispanic adults; and adults with less than a college degree. Stroke prevalence decreased in DC and had a statistically significant increase in 10 states.
  • #11 Neurobehavioural consequences of stroke – Epidemiology and global impact – Neurotorium
    https://neurotorium.org/slidedeck/neurobehavioural-consequences-of-stroke-epidemiology-and-global-impact/
    Stroke is a burdensome condition. In 2019, it was estimated that there were 12.22 million incident cases of stroke and 6.55 million deaths due to stroke. This slide deck discusses the epidemiology and burden of stroke and the epidemiology and impact of neurobehavioral consequences of stroke. […] Stroke is common across the world, and increased substantially between 1990-2019. The greatest rates of stroke burden are seen in low-income countries. In order to combat these increases, and halt the increases in the prevalence of stroke worldwide, effective primary prevention strategies are needed. […] Data from the Global Burden of Disease surveys have been used to model the global, regional, and national burden of stroke and its risk factors, between 1990-2019. The analysis also modelled disability-adjusted life years (DALYs) due to the various risk factors of stroke.
  • #12 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    The risk of having a stroke varies with race and ethnicity. […] Risk of having a first stroke is nearly twice as high for non-Hispanic Black adults as for White adults. […] Non-Hispanic Black adults and Pacific Islander adults have the highest rates of death from stroke. […] High blood pressure, high cholesterol, smoking, obesity, and diabetes are leading causes of stroke. […] CDC and its partners are leading national initiatives and programs to reduce rates of death and disability caused by stroke and to help people live longer, healthier lives. […] The Paul Coverdell National Acute Stroke Program funds states to measure, track, and improve the quality of care for stroke patients. The program works to reduce death and disability from stroke.
  • #13 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    Stroke statistics vary by race and ethnicity. […] In the United States in 2022, 1 in 6 deaths (17.5%) from cardiovascular disease was due to stroke. […] The death rate for stroke decreased from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. […] Every year, more than 795,000 people in the United States have a stroke. […] About 610,000 of these are first or new strokes. […] About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. […] About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. […] Stroke-related costs in the United States came to nearly $56.2 billion between 2019 and 2020. […] Stroke is a leading cause of serious long-term disability. […] Stroke reduces mobility in more than half of stroke survivors age 65 and older.
  • #14 Epidemiology, Pathophysiology, and Current Treatment Strategies in Stroke
    http://www.fortunejournals.com/articles/epidemiology-pathophysiology-and-current-treatment-strategies-in-stroke.html
    Both ischemic and hemorrhagic strokes are critical health issues and the incidence is on the rise. […] Clinical trials show conflicting findings, with ischemic strokes accounting for 87% of all strokes. […] Because of demographic factors like age, sex, race/ethnicity, and socioeconomic status, the incidence and prevalence of stroke differ across people and regions. […] Globally, stroke is the second leading cause of death and a significant contributor to long-term disability. […] According to the Global Burden of Disease Study 2020, the global prevalence of all stroke subtypes of 89.13 million cases and the age-standardized stroke prevalence rates were highest in sub-Saharan Africa and in certain regions of the Southeast United States and East and Southeast Asia. […] The global incidence of stroke was 11.71 million people, and the incidence of ischemic stroke, intracerebral hemorrhage, and subarachnoid hemorrhage was 7.59 million, 3.41 million, and 0.71 million people, respectively.
  • #15 Stroke Epidemiology and Near Future Projection in Turkey: Analysis of Turkey Data from the Global Burden of Disease Study | 2022, Volume 28 – Issue 4 | Turkish Journal of Neurology
    https://tjn.org.tr/full-text/65/eng
    The most up-to-date stroke statistics for Turkey are presented using the Global Burden of Disease e-research system. In 2019, the incidence of stroke for Turkey was estimated as 125,345 (154 per hundred thousand), the prevalence was 1,080,380 (1.3%), the death rate due to stroke was 48,947 and the number of life years lost due to stroke-related death/disability was estimated to be 993,082 years. Of strokes 17.4% occurred under the age of fifty, 58.5% under the age of seventy, and 54.3% in women. 65.1% of strokes are acute ischemic stroke, 24% intracerebral and 10.9% subarachnoid hemorrhage. Although there is a numerical increase in all stroke types with the aging of our country’s population, it has been observed that the increase in the frequency of hemorrhagic strokes are limited over time when frequency standardization is made according to age.
  • #16 Prevalence of Stroke — Behavioral Risk Factor Surveillance System, United States, 2011–2022 | MMWR
    https://www.cdc.gov/mmwr/volumes/73/wr/mm7320a1.htm
    Identifying and understanding demographic factors associated with stroke, and disparities in stroke prevalence, might help focus programmatic and clinical interventions to improve the prevention and treatment of stroke at state and national levels. Effective national programs, such as the Million Hearts 2027 initiative, maintain a repository of sustainable interventions focused on stroke risk factor prevention and improvement in clinical management that can be replicated across diverse communities.
  • #17 Epidemiology, Pathophysiology, and Current Treatment Strategies in Stroke
    http://www.fortunejournals.com/articles/epidemiology-pathophysiology-and-current-treatment-strategies-in-stroke.html
    Age is the strongest non-modifiable risk factor for stroke and elderly patients with strokes typically have higher mortality rates and reduced ability for functional recovery. […] Historically, it has been well-documented that the incidence of stroke is higher in men compared to women. […] However, recent studies have shown that there is a decrease in ischemic stroke among men which means that the incidence of stroke is declining more in men than women and the overall incidence of stroke is decreasing over time. […] Stroke is a leading cause of death and disability worldwide. […] The two main causes of stroke are occlusion of blood vessels (ischemic stroke) and rupture of brain vessels (hemorrhagic stroke).
  • #18 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    The incidence of stroke rapidly increases with age, doubling for each decade after age 55. […] Perhaps due to better control of vascular risk factors during the last decade, incidence rates of stroke in developed nations have modestly diminished or plateaued. […] It has been projected that with continued aging of the population, especially in Western countries, these rates are expected to rise again dramatically during the next 40 years. […] Understanding the factors that are associated with clinical outcomes can lead to more effective interventions to reduce case fatality and mortality, and to improve functional status in patients with stroke. […] In general, the trends in stroke incidence and mortality rates have decreased in the recent decades for high-income countries such as the U.S., the United Kingdom, and Canada.
  • #19 Ischemic Stroke: Background, Anatomy, Pathophysiology
    https://emedicine.medscape.com/article/1916852-overview
    Stroke is the leading cause of disability and the fifth leading cause of death in the United States. Each year, approximately 795,000 people in the United States experience new (610,000 people) or recurrent (185,000 people) stroke. Epidemiologic studies indicate that 8292% of strokes in the United States are ischemic. […] According to the World Health Organization (WHO), 15 million people suffer stroke worldwide each year. Of these, 5 million die, and another 5 million are left permanently disabled. […] In the United States, Blacks have an age-adjusted risk of death from stroke that is 1.49 times that of Whites. Hispanics have a lower overall incidence of stroke than Whites and Blacks but more frequent lacunar strokes and stroke at an earlier age. Indigenous people in high-income countries have higher incidence of stroke than non-indigenous people. Men are at higher risk for stroke than women; White men have a stroke incidence of 62.8 per 100,000, with death being the final outcome in 26.3% of cases, while women have a stroke incidence of 59 per 100,000 and a death rate of 39.2%. […] Although stroke often is considered a disease of elderly persons, one third of strokes occur in persons younger than 65 years. Risk of stroke increases with age, especially in patients older than 64 years, in whom 75% of all strokes occur.
  • #20 Epidemiology, Pathophysiology, and Current Treatment Strategies in Stroke
    http://www.fortunejournals.com/articles/epidemiology-pathophysiology-and-current-treatment-strategies-in-stroke.html
    Age is the strongest non-modifiable risk factor for stroke and elderly patients with strokes typically have higher mortality rates and reduced ability for functional recovery. […] Historically, it has been well-documented that the incidence of stroke is higher in men compared to women. […] However, recent studies have shown that there is a decrease in ischemic stroke among men which means that the incidence of stroke is declining more in men than women and the overall incidence of stroke is decreasing over time. […] Stroke is a leading cause of death and disability worldwide. […] The two main causes of stroke are occlusion of blood vessels (ischemic stroke) and rupture of brain vessels (hemorrhagic stroke).
  • #21 Ischemic Stroke: Background, Anatomy, Pathophysiology
    https://emedicine.medscape.com/article/1916852-overview
    Stroke is the leading cause of disability and the fifth leading cause of death in the United States. Each year, approximately 795,000 people in the United States experience new (610,000 people) or recurrent (185,000 people) stroke. Epidemiologic studies indicate that 8292% of strokes in the United States are ischemic. […] According to the World Health Organization (WHO), 15 million people suffer stroke worldwide each year. Of these, 5 million die, and another 5 million are left permanently disabled. […] In the United States, Blacks have an age-adjusted risk of death from stroke that is 1.49 times that of Whites. Hispanics have a lower overall incidence of stroke than Whites and Blacks but more frequent lacunar strokes and stroke at an earlier age. Indigenous people in high-income countries have higher incidence of stroke than non-indigenous people. Men are at higher risk for stroke than women; White men have a stroke incidence of 62.8 per 100,000, with death being the final outcome in 26.3% of cases, while women have a stroke incidence of 59 per 100,000 and a death rate of 39.2%. […] Although stroke often is considered a disease of elderly persons, one third of strokes occur in persons younger than 65 years. Risk of stroke increases with age, especially in patients older than 64 years, in whom 75% of all strokes occur.
  • #22 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    The risk of having a stroke varies with race and ethnicity. […] Risk of having a first stroke is nearly twice as high for non-Hispanic Black adults as for White adults. […] Non-Hispanic Black adults and Pacific Islander adults have the highest rates of death from stroke. […] High blood pressure, high cholesterol, smoking, obesity, and diabetes are leading causes of stroke. […] CDC and its partners are leading national initiatives and programs to reduce rates of death and disability caused by stroke and to help people live longer, healthier lives. […] The Paul Coverdell National Acute Stroke Program funds states to measure, track, and improve the quality of care for stroke patients. The program works to reduce death and disability from stroke.
  • #23
    https://journals.lww.com/annalsofian/fulltext/2007/10030/surveillance_of_stroke__who_step_wise_approach__a.5.aspx
    Hypertension is the most significant risk factor for the occurrence of stroke, but the stroke outcome was not significantly affected by the presence of hypertension, as the number of hypertensives with favourable outcomes and those with increased morbidity and mortality were about the same. […] The outcome of stroke essentially depends on the type of stroke, the severity, and the subtype. However the morbidity and mortality of stroke, as determined by the outcome at 4 weeks by the MRS, is significantly higher in elderly patients with diabetes and IHD and in smokers. […] Heightened public awareness of the risk factors and their management not only aids primary prevention of stroke, it also leads to early treatment and better stroke outcomes.
  • #24 WHO EMRO | Stroke, Cerebrovascular accident | Health topics
    https://www.emro.who.int/health-topics/stroke-cerebrovascular-accident/index.html
    High blood pressure and tobacco use are the most significant modifiable risks. For every 10 people who die of stroke, four could have been saved if their blood pressure had been regulated. Among those aged under 65, two-fifths of deaths from stroke are linked to smoking. Atrial fibrillation, heart failure and heart attack are other important risk factors. The incidence of stroke is declining in many developed countries, largely as a result of better control of high blood pressure and reduced levels of smoking. However, the absolute number of strokes continues to increase because of the ageing population.
  • #25 Epidemiology, Pathophysiology, and Current Treatment Strategies in Stroke
    http://www.fortunejournals.com/articles/epidemiology-pathophysiology-and-current-treatment-strategies-in-stroke.html
    In the United States alone in 2021, 1 in 6 cardiovascular disease-related deaths were due to stroke. […] Transient ischemic attack (TIA) occurs due to a transient obstruction of blood flow to the brain that results in temporary neurological deficits that typically resolve on their own. […] A recent INTERSTROKE study from 2016 analyzed the potential effects of modifiable risk factors associated with stroke in 32 countries. […] Among the 13,000 stroke cases, it was shown that modifiable risk factors such as diet, physical inactivity, hypertension, psychosocial factors, cardiac causes, diabetes, smoking, abdominal obesity, hyperlipidemia, and alcohol consumption accounted for approximately 90% of all strokes. […] Hypertension is the most important modifiable risk factor for stroke. […] Diabetes is another well-established modifiable risk factor for stroke.
  • #26 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #27 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #28 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #29
    https://journals.lww.com/annalsofian/fulltext/2007/10030/surveillance_of_stroke__who_step_wise_approach__a.5.aspx
    Stroke is potentially the most devastating consequence of vascular disease, causing long-term disability and placing high medical, emotional, and financial burdens on the patient. WHO STEPS stroke surveillance study, provided the framework for our study of stroke patients in Chennai. […] The objective of the study was to analyze the data profile of our stroke patients and to assess the outcome of our protocol for treating patients with stroke. […] The WHO stroke surveillance part of the study focuses on hospitalized stroke patients only (STEP-1). […] The risk factors of age, hypertension, diabetes mellitus, ischemic heart disease (IHD), dyslipidemia, anemia, and nicotine intake were evaluated. […] Hypertension was found to be a major risk factor of stroke in 72% of the patients. […] The result of the multiple logistic regression analysis shows an increase in morbidity and mortality, with the MRS scores more than 5, in the presence of risk factors such as age, diabetes mellitus, and IHD.
  • #30 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    The risk of having a stroke varies with race and ethnicity. […] Risk of having a first stroke is nearly twice as high for non-Hispanic Black adults as for White adults. […] Non-Hispanic Black adults and Pacific Islander adults have the highest rates of death from stroke. […] High blood pressure, high cholesterol, smoking, obesity, and diabetes are leading causes of stroke. […] CDC and its partners are leading national initiatives and programs to reduce rates of death and disability caused by stroke and to help people live longer, healthier lives. […] The Paul Coverdell National Acute Stroke Program funds states to measure, track, and improve the quality of care for stroke patients. The program works to reduce death and disability from stroke.
  • #31 China stroke surveillance report 2021 | Military Medical Research | Full Text
    https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00463-x
    Data from 1599 hospitals in the Hospital Quality Monitoring System and Bigdata Observatory Platform for Stroke of China (BOSC) showed that a total of 3,418,432 stroke cases were admitted during 2020. […] The China Stroke Surveillance Report 2021 refers to China’s latest major research results. […] The report primarily focuses on several areas, including the progress made in stroke diagnosis and treatment, the development of China’s stroke prevention and control system, the construction of the Bigdata Observatory Platform for Stroke of China (BOSC), data analysis of screening and intervention projects for high-risk stroke groups, prospects for stroke prevention and treatment, and the primary tasks and goals for future stroke prevention and control efforts. […] The epidemiological characteristics of stroke in China are mainly as follows: 1) age characteristics, younger-onset (average age 65 years); 2) regional differences, high in the North and low in the South, and prominent in the middle; 3) differences between urban and rural areas, high in rural areas; 4) gender differences, high in men.
  • #32 China stroke surveillance report 2021 | Military Medical Research | Full Text
    https://mmrjournal.biomedcentral.com/articles/10.1186/s40779-023-00463-x
    Data from 1599 hospitals in the Hospital Quality Monitoring System and Bigdata Observatory Platform for Stroke of China (BOSC) showed that a total of 3,418,432 stroke cases were admitted during 2020. […] The China Stroke Surveillance Report 2021 refers to China’s latest major research results. […] The report primarily focuses on several areas, including the progress made in stroke diagnosis and treatment, the development of China’s stroke prevention and control system, the construction of the Bigdata Observatory Platform for Stroke of China (BOSC), data analysis of screening and intervention projects for high-risk stroke groups, prospects for stroke prevention and treatment, and the primary tasks and goals for future stroke prevention and control efforts. […] The epidemiological characteristics of stroke in China are mainly as follows: 1) age characteristics, younger-onset (average age 65 years); 2) regional differences, high in the North and low in the South, and prominent in the middle; 3) differences between urban and rural areas, high in rural areas; 4) gender differences, high in men.
  • #33 National surveillance of stroke quality of care and outcomes by applying post-stratification survey weights on the Get With The Guidelines-Stroke patient registry.
    https://escholarship.org/uc/item/10n978vg
    The U.S. lacks a stroke surveillance system. This study develops a method to transform an existing registry into a nationally representative database to evaluate acute ischemic stroke care quality. […] Leveraging existing databases with patient registries to develop post-stratification weights is a reliable approach to estimate acute ischemic stroke epidemiology and monitoring for stroke quality of care nationally. These methods may be applied to other diseases or settings to better monitor population health.
  • #34 High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0213035
    High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery […] Visual problems are an under-reported sequela following stroke. The aim of this study is to report annual incidence and point prevalence of visual problems in an acute adult stroke population and to explore feasibility of early timing of visual assessment. […] Multi-centre acute stroke unit, prospective, epidemiology study (1st July 2014 to 30th June 2015). Orthoptists reviewed all patients with assessment of visual acuity, visual fields, ocular alignment, ocular motility, visual inattention and visual perception. 1033 patients underwent visual screening at a median of 3 days (IQR 2) and full visual assessment at a median of 4 days (IQR 7) after the incident stroke: 52% men, 48% women, mean age 73 years and 87% ischaemic strokes. Excluding pre-existent eye problems, the incidence of new onset visual sequelae was 48% for all stroke admissions and 60% in stroke survivors. Three quarters 752/1033 (73%) had visual problems (point prevalence): 56% with impaired central vision, 40% eye movement abnormalities, 28% visual field loss, 27% visual inattention, 5% visual perceptual disorders. 281/1033 (27%) had normal eye exams.
  • #35 High incidence and prevalence of visual problems after acute stroke: An epidemiology study with implications for service delivery | PLOS One
    https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0213035
    Incidence and point prevalence of visual problems in acute stroke is alarmingly high, affecting over half the survivors. For most, visual screening and full visual assessment was achieved within about 5 days of stroke onset. Crucial information can thus be provided on visual status and its functional significance to the stroke team, patients and carers, enabling early intervention. […] Accurate information about incidence of visual sequelae and timing of visual assessment is important when considering the needs of stroke survivors and developing services for appropriate and adequate patient care. […] The aim of this study was to determine the incidence and point prevalence of visual problems in an acute stroke population and to explore the timing at which visual assessment can be first undertaken in this population.
  • #36 Heart Disease Stroke Surveillance System
    https://portal.ct.gov/dph/Health-Information-Systems–Reporting/Hisrhome/Heart-Disease–Stroke-Surveillance-System
    Public health tracking of heart disease and stroke is an essential part of reducing the disease burden in Connecticut, identifying high-risk groups, formulating health care policy, and evaluating our states progress in preventing this disease. […] The objective of the Connecticut Heart Disease Stroke Surveillance System (CHDSS) is to provide timely and relevant information about heart disease, stroke and their complications in Connecticut, as well as related risk factor information. […] Please see the Mortality Statistics page heart disease, stroke, and cardiovascular disease-related death counts; age-adjusted mortality and premature mortality rates; and mortality disparities by gender, race, and ethnicity.
  • #37 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #38 Stroke in the 21st Century: A Snapshot of the Burden, Epidemiology, and Quality of Life
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6288566/
    Stroke is ranked as the second leading cause of death worldwide with an annual mortality rate of about 5.5 million. […] The public health burden of stroke is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke has a huge public health burden, which is set to rise over future decades because of demographic transitions of populations, particularly in developing countries. […] Stroke is a disease of immense public health importance with serious economic and social consequences. […] Stroke surveillance forms an important component of the overall control of stroke as it provides information about etiology, risk, prognosis, prevention, and intervention as well as disease distribution and time trends. […] The WHO has proposed a surveillance system for stroke involving three steps, which represent the possible initial outcomes for stroke patients: events in hospital, fatal events in community, and nonfatal events in community. […] The WHO stepwise approach to stroke surveillance provides a flexible system and an opportunity for all countries to contribute data on stroke.
  • #39 Epidemiology of Stroke: A Comprehensive Overview
    https://www.openaccessjournals.com/articles/epidemiology-of-stroke-a-comprehensive-overview-18440.html
    The global distribution of stroke highlights significant disparities between high-income and low-income countries. […] In HICs, healthcare infrastructure, early detection and preventive measures have led to a decline in stroke mortality rates. […] In contrast, LMICs face a growing stroke burden due to limited resources, lack of awareness and inadequate healthcare access. […] Stroke imposes a significant economic burden on healthcare systems. […] In the United States alone, the annual direct and indirect costs of stroke are estimated to exceed $50 billion. […] Understanding the epidemiology of stroke is essential for developing effective prevention, treatment and rehabilitation strategies.
  • #40 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    Stroke statistics vary by race and ethnicity. […] In the United States in 2022, 1 in 6 deaths (17.5%) from cardiovascular disease was due to stroke. […] The death rate for stroke decreased from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. […] Every year, more than 795,000 people in the United States have a stroke. […] About 610,000 of these are first or new strokes. […] About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. […] About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. […] Stroke-related costs in the United States came to nearly $56.2 billion between 2019 and 2020. […] Stroke is a leading cause of serious long-term disability. […] Stroke reduces mobility in more than half of stroke survivors age 65 and older.
  • #41 Stroke Epidemiology, Etiology, and Background | Anesthesia Key
    https://aneskey.com/stroke-epidemiology-etiology-and-background/
    Country Age-adjusted mortality rate per 100,000 per year Canada 25.7 USA 30.4 Australia 32.6 United Kingdom 45.6 Kyrgyzstan 249.4 India 108 China 156.5 Russian Federation 228 South Africa 141.1 Nigeria 152.8 Brazil 91.1 Pakistan 117.9 […] Estimates suggest that stroke consumes 24 % of the total healthcare costs globally. In developed nations this proportion exceeds 4 % of healthcare costs. […] In the United States, the estimated cost of stroke in 2008 was $34.3 billion; this includes direct medical costs of $18.8 billion. […] United States data estimates the annual stroke incidence to be 795,000, of which approximately 610,000 are first-time strokes. […] In the United States, stroke as a cause of death declined by 19 % from 1998 to 2008 so that it is now the fourth most common cause of death.
  • #42 World Stroke Organization
    https://www.world-stroke.org/world-stroke-day-campaign/about-stroke/impact-of-stroke
    Stroke is a leading cause of death and disability worldwide. Globally, 1 in 4 adults over the age of 25 will have a stroke in their lifetime. […] Over 12 million people worldwide will have their first stroke this year and 6.5 million will die as a result. Over 100 million people in the world have experienced stroke. The incidence of stroke increases significantly with age, however over 60% of strokes happen to people under the age of 70 and 16% happen to those under the age of 50. […] Rates of stroke are growing fastest in low and middle income countries, often where healthcare providers find it more challenging to provide the care that is needed for effective prevention, treatment and rehabilitation of stroke. […] The global economic impact of stroke currently represents 0.66% of Global GDP and the total cost of stroke is estimated to tip US$1 trillion by 2030.
  • #43 Epidemiology of Stroke: A Comprehensive Overview
    https://www.openaccessjournals.com/articles/epidemiology-of-stroke-a-comprehensive-overview-18440.html
    The global distribution of stroke highlights significant disparities between high-income and low-income countries. […] In HICs, healthcare infrastructure, early detection and preventive measures have led to a decline in stroke mortality rates. […] In contrast, LMICs face a growing stroke burden due to limited resources, lack of awareness and inadequate healthcare access. […] Stroke imposes a significant economic burden on healthcare systems. […] In the United States alone, the annual direct and indirect costs of stroke are estimated to exceed $50 billion. […] Understanding the epidemiology of stroke is essential for developing effective prevention, treatment and rehabilitation strategies.
  • #44 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    Stroke statistics vary by race and ethnicity. […] In the United States in 2022, 1 in 6 deaths (17.5%) from cardiovascular disease was due to stroke. […] The death rate for stroke decreased from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. […] Every year, more than 795,000 people in the United States have a stroke. […] About 610,000 of these are first or new strokes. […] About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. […] About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. […] Stroke-related costs in the United States came to nearly $56.2 billion between 2019 and 2020. […] Stroke is a leading cause of serious long-term disability. […] Stroke reduces mobility in more than half of stroke survivors age 65 and older.
  • #45
    https://journals.lww.com/annalsofian/fulltext/2007/10030/surveillance_of_stroke__who_step_wise_approach__a.5.aspx
    Stroke is potentially the most devastating consequence of vascular disease, causing long-term disability and placing high medical, emotional, and financial burdens on the patient. WHO STEPS stroke surveillance study, provided the framework for our study of stroke patients in Chennai. […] The objective of the study was to analyze the data profile of our stroke patients and to assess the outcome of our protocol for treating patients with stroke. […] The WHO stroke surveillance part of the study focuses on hospitalized stroke patients only (STEP-1). […] The risk factors of age, hypertension, diabetes mellitus, ischemic heart disease (IHD), dyslipidemia, anemia, and nicotine intake were evaluated. […] Hypertension was found to be a major risk factor of stroke in 72% of the patients. […] The result of the multiple logistic regression analysis shows an increase in morbidity and mortality, with the MRS scores more than 5, in the presence of risk factors such as age, diabetes mellitus, and IHD.
  • #46 Stroke Facts | Stroke | CDC
    https://www.cdc.gov/stroke/data-research/facts-stats/index.html
    Stroke statistics vary by race and ethnicity. […] In the United States in 2022, 1 in 6 deaths (17.5%) from cardiovascular disease was due to stroke. […] The death rate for stroke decreased from 41.1 per 100,000 in 2021 to 39.5 per 100,000 in 2022. […] Every year, more than 795,000 people in the United States have a stroke. […] About 610,000 of these are first or new strokes. […] About 185,000 strokes nearly 1 in 4 are in people who have had a previous stroke. […] About 87% of all strokes are ischemic strokes, in which blood flow to the brain is blocked. […] Stroke-related costs in the United States came to nearly $56.2 billion between 2019 and 2020. […] Stroke is a leading cause of serious long-term disability. […] Stroke reduces mobility in more than half of stroke survivors age 65 and older.
  • #47
    https://journals.lww.com/annalsofian/fulltext/2007/10030/surveillance_of_stroke__who_step_wise_approach__a.5.aspx
    Hypertension is the most significant risk factor for the occurrence of stroke, but the stroke outcome was not significantly affected by the presence of hypertension, as the number of hypertensives with favourable outcomes and those with increased morbidity and mortality were about the same. […] The outcome of stroke essentially depends on the type of stroke, the severity, and the subtype. However the morbidity and mortality of stroke, as determined by the outcome at 4 weeks by the MRS, is significantly higher in elderly patients with diabetes and IHD and in smokers. […] Heightened public awareness of the risk factors and their management not only aids primary prevention of stroke, it also leads to early treatment and better stroke outcomes.
  • #48 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    Epidemiologic studies on stroke help us with understanding the natural history of the disease, identification of risk factors, and prognostic factors that can lead to markers for disease mechanisms. Epidemiology and observational data can inform scientists of possible novel areas for more focused research. They help us identify the individuals, groups, or geographic areas that are at increased risk of disease or poorer outcomes. Critical analyses of the factors that are involved in those cases of higher risks and poorer outcomes can lead to a better understanding of the underlying causes. Furthermore, knowing which individuals, groups, or geographic areas are at risk helps physicians and public health policymakers to develop more effective target programs to reduce the risk of stroke, stroke mortality, and disability.
  • #49
    https://journals.lww.com/continuum/fulltext/2020/04000/epidemiology_and_primary_prevention_of_stroke.4.aspx
    PURPOSE OF REVIEW This article provides an update on the epidemiology and prevention of a first stroke. Risk factor modification plays a large role in stroke prevention. Strategies for early intervention, particularly for hypertension, are critical for reducing stroke morbidity and mortality. […] SUMMARY Primary prevention of stroke is essential for maintaining brain health throughout the life span. Adherence to a healthy lifestyle and routine screening for stroke risk factors can promote healthy, stroke-free aging.
  • #50
    https://journals.lww.com/continuum/fulltext/2020/04000/epidemiology_and_primary_prevention_of_stroke.4.aspx
    PURPOSE OF REVIEW This article provides an update on the epidemiology and prevention of a first stroke. Risk factor modification plays a large role in stroke prevention. Strategies for early intervention, particularly for hypertension, are critical for reducing stroke morbidity and mortality. […] SUMMARY Primary prevention of stroke is essential for maintaining brain health throughout the life span. Adherence to a healthy lifestyle and routine screening for stroke risk factors can promote healthy, stroke-free aging.
  • #51
    https://journals.lww.com/annalsofian/fulltext/2007/10030/surveillance_of_stroke__who_step_wise_approach__a.5.aspx
    Hypertension is the most significant risk factor for the occurrence of stroke, but the stroke outcome was not significantly affected by the presence of hypertension, as the number of hypertensives with favourable outcomes and those with increased morbidity and mortality were about the same. […] The outcome of stroke essentially depends on the type of stroke, the severity, and the subtype. However the morbidity and mortality of stroke, as determined by the outcome at 4 weeks by the MRS, is significantly higher in elderly patients with diabetes and IHD and in smokers. […] Heightened public awareness of the risk factors and their management not only aids primary prevention of stroke, it also leads to early treatment and better stroke outcomes.
  • #52 Prevalence of Stroke — Behavioral Risk Factor Surveillance System, United States, 2011–2022 | MMWR
    https://www.cdc.gov/mmwr/volumes/73/wr/mm7320a1.htm
    Identifying and understanding demographic factors associated with stroke, and disparities in stroke prevalence, might help focus programmatic and clinical interventions to improve the prevention and treatment of stroke at state and national levels. Effective national programs, such as the Million Hearts 2027 initiative, maintain a repository of sustainable interventions focused on stroke risk factor prevention and improvement in clinical management that can be replicated across diverse communities.
  • #53 Open Access Macedonian Journal of Medical Sciences (OAMJMS).
    https://oamjms.eu/index.php/mjms/article/view/11505
    According to the official statistics of the Ministry of Health, 40 thousand cases of stroke are registered annually in Kazakhstan. […] The aim of the study was to study the prevalence of stroke among the population of Kazakhstan and the organization of medical care in hospitals for the years 20182020. […] The availability of medical care for stroke is of great importance. As the analysis of survival rate showed, the average survival time directly depends on the patients condition at admission to hospitals. The survival rate of patients with various nosologies of cerebral circulation in men and women differs significantly and reaches 80 years. […] The correct organization of the management of medical care for patients with acute circulatory disorders is of paramount importance. It is necessary to strengthen the integration and coordination of the systems of emergency care and primary health care.
  • #54 Open Access Macedonian Journal of Medical Sciences (OAMJMS).
    https://oamjms.eu/index.php/mjms/article/view/11505
    According to the official statistics of the Ministry of Health, 40 thousand cases of stroke are registered annually in Kazakhstan. […] The aim of the study was to study the prevalence of stroke among the population of Kazakhstan and the organization of medical care in hospitals for the years 20182020. […] The availability of medical care for stroke is of great importance. As the analysis of survival rate showed, the average survival time directly depends on the patients condition at admission to hospitals. The survival rate of patients with various nosologies of cerebral circulation in men and women differs significantly and reaches 80 years. […] The correct organization of the management of medical care for patients with acute circulatory disorders is of paramount importance. It is necessary to strengthen the integration and coordination of the systems of emergency care and primary health care.
  • #55 The epidemiology and management of stroke in French Guiana | BMC Neurology | Full Text
    https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-020-01650-2
    French Guiana has the highest incidence of ischemic and hemorrhagic stroke of all French territories. However, there is no further information on the epidemiology and management of stroke in French Guiana. Our goal was to describe the characteristics of patients in French Guiana in order to generate hypotheses regarding the determinants explaining the magnitude of this public health problem. […] The present study is the first epidemiologic description of stroke in French Guiana. The comparisons of these results show that stroke patients in French Guiana are epidemiologically atypical because they are younger, and more likely to be males than patients in mainland France. Stroke risk factors and delay between stroke and hospital admission were comparable with what is observed in France, suggesting that efforts should focus on primary care and social inequalities of health to alleviate the main determinants of stroke in French Guiana.
  • #56 The epidemiology and management of stroke in French Guiana | BMC Neurology | Full Text
    https://bmcneurol.biomedcentral.com/articles/10.1186/s12883-020-01650-2
    Although it was known that the incidence of stroke was high, the present study provides the first epidemiological data on strokes in French Guiana. The comparison of the results of the present descriptive study with those of French stroke registries showed that the proportion of ischemic to hemorrhagic strokes and the frequency of risk factors were similar in French Guiana and France, but underlined that strokes in French Guiana affected younger patients, and more males than in mainland France.
  • #57 Stroke Epidemiology and Near Future Projection in Turkey: Analysis of Turkey Data from the Global Burden of Disease Study | 2022, Volume 28 – Issue 4 | Turkish Journal of Neurology
    https://tjn.org.tr/full-text/65/eng
    Over the last 30 years, the combined incidence of all hemorrhagic and ISs has increased by 117% with a fairly stable acceleration, increasing from 57,650 (97 per 100,000) to 125,235 (154 per 100,000). […] The number of patients diagnosed as having SAH was 7,849 in 1990, increasing by 75% in approximately thirty years to reach 13,719 in 2019. […] The number of deaths from ICH increased markedly between 2000 and 2010, and remained approximately stable in the previous and subsequent decades (approximately 75% increase from 8,635 to 15,901 between 2000 and 2010). […] The number of life years lost due to death and disability due to ICH increased from 256,093 in 1990 to 350,129 in 2019 with an increase of 37%. […] Based on the current population characteristics in Turkey, it is inevitable that acute stroke will continue to be an important public health problem.
  • #58 Advances in treatments for acute ischemic stroke | The BMJ
    https://www.bmj.com/content/389/bmj-2023-076161
    In 2021, 69.93 million people worldwide had an ischemic stroke, representing a 1.33% decrease since 2010. […] In 2021, 7.44 million deaths caused by ischemic stroke were recorded, which represented a 17.39% decrease since 2010, with the highest mortality seen in Oceania and South East Asia. […] Although the absolute number of ischemic strokes increased by 70% since 1990, potentially owing to the increase in the worlds population, the incidence decreased by 17% between 1990 and 2019, likely because of decreased prevalence of stroke risk factors such as hypertension and diabetes. […] Stroke affects patients disproportionately. […] In the United States, black people have a higher risk of stroke and are less likely to undergo thrombectomy compared with white people. […] Risk factors for stroke are also disproportionate.
  • #59 Stroke in Young Adults in Spain: Epidemiology and Risk Factors by Age
    https://www.mdpi.com/2075-4426/13/5/768
    A significant rise in the incidence of IS among young patients has been observed in recent epidemiological studies conducted in both Europe and North America. This trend was also evident during the period analyzed in this research. […] Young adults who experience IS have been found to have higher rates of vascular risk factors compared to the general population, a trend also observed in this study when compared to the percentage of these risk factors in the same age group from a population-based survey representative of the Spanish population. […] The present study evaluated the incidence of IS in Spain according to sex and age groups using data from a national hospital admission registry. The results indicated that the estimated incidence of IS was consistently higher among men across all age groups, compared to women. Furthermore, the studied cohort exhibited a greater prevalence of most vascular risk factors when compared to the overall Spanish population. These risk factors were distributed differently across genders and age groups, highlighting the need for careful consideration when planning primary and secondary prevention strategies.
  • #60 Epidemiology of Stroke: A Comprehensive Overview
    https://www.openaccessjournals.com/articles/epidemiology-of-stroke-a-comprehensive-overview-18440.html
    The global distribution of stroke highlights significant disparities between high-income and low-income countries. […] In HICs, healthcare infrastructure, early detection and preventive measures have led to a decline in stroke mortality rates. […] In contrast, LMICs face a growing stroke burden due to limited resources, lack of awareness and inadequate healthcare access. […] Stroke imposes a significant economic burden on healthcare systems. […] In the United States alone, the annual direct and indirect costs of stroke are estimated to exceed $50 billion. […] Understanding the epidemiology of stroke is essential for developing effective prevention, treatment and rehabilitation strategies.
  • #61 Epidemiology, Pathophysiology, and Management of Cancer-Associated Ischemic Stroke
    https://www.mdpi.com/2072-6694/16/23/4016
    The risk of stroke in patients with cancer is highest amongst patients with distant metastases and within six months of diagnosis. The risk of stroke appears to correlate with the aggressiveness of the cancer itself, as metastatic lung, pancreatic, and colorectal cancers appear to carry the highest risk. […] In approximately half of cancer patients diagnosed with ischemic stroke, the etiology of ischemic stroke remains undetermined after standard diagnostic imaging and evaluation, with the estimated proportion of embolic stroke of undetermined source (ESUS) patients with cancer approaching 10%, although it may be as high as 20% in some Asian populations. […] Further evidence has suggested that cancer-associated ischemic stroke, specifically embolic stroke, is a distinct subtype of stroke. There is not yet a reliable serum biomarker for cancer-associated ischemic stroke, though progress has been made regarding improving the diagnosis of cancer in patients with cryptogenic stroke. […] The aim of this narrative review is to comprehensively examine epidemiology, pathophysiology, prevention, treatment, recovery, and future directions regarding CAIS.
  • #62 Global, regional, and national burden of stroke and its risk factors, 1990–2021 | Institute for Health Metrics and Evaluation
    https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021
    Stroke burden has increased from 1990 to 2021, and the contribution of several risk factors has also increased. Effective, accessible, and affordable measures to improve stroke surveillance, prevention (with the emphasis on blood pressure, lifestyle, and environmental factors), acute care, and rehabilitation need to be urgently implemented across all countries to reduce stroke burden.
  • #63 Global, regional, and national burden of stroke and its risk factors, 1990–2021 | Institute for Health Metrics and Evaluation
    https://www.healthdata.org/research-analysis/library/global-regional-and-national-burden-stroke-and-its-risk-factors-1990-2021
    In 2021, stroke was the third most common GBD level 3 cause of death, after ischemic heart disease and COVID-19, constituting 10.7% of all deaths. […] Up-to-date estimates of stroke burden and attributable risks and their trends at global, regional, and national levels are essential for evidence-based health care, prevention, and resource allocation planning. […] We estimated incidence, prevalence, death, and disability-adjusted life-year (DALY) counts and age-standardised rates per 100000 people per year for overall stroke, ischaemic stroke, intracerebral haemorrhage, and subarachnoid haemorrhage, for 204 countries and territories from 1990 to 2021. […] We found disparities in stroke burden and risk factors by GBD region, country or territory, and SDI, as well as a stagnation in the reduction of incidence from 2015 onwards, and even some increases in the stroke incidence, death, prevalence, and DALY rates in southeast Asia, east Asia, and Oceania, countries with lower SDI, and people younger than 70 years.
  • #64 Stroke Epidemiology: Advancing Our Understanding of Disease Mechanism and Therapy
    https://pmc.ncbi.nlm.nih.gov/articles/PMC3250269/
    While there have been reports of decreased stroke incidence and mortality in high-income countries, the opposite has been observed in low-to-middle income countries. […] Although advancement in stroke prevention and management has led to many successes in the fight against this disease for the past 2 decades, many challenges remain as clinicians and investigators continue to try and uncover the underlying causes behind the many disparities in stroke burden and outcome observed in epidemiologic studies to be able to design interventions to improve stroke mortality and disability for all.
  • #65 Stroke Epidemiology, Etiology, and Background | Anesthesia Key
    https://aneskey.com/stroke-epidemiology-etiology-and-background/
    Country Age-adjusted mortality rate per 100,000 per year Canada 25.7 USA 30.4 Australia 32.6 United Kingdom 45.6 Kyrgyzstan 249.4 India 108 China 156.5 Russian Federation 228 South Africa 141.1 Nigeria 152.8 Brazil 91.1 Pakistan 117.9 […] Estimates suggest that stroke consumes 24 % of the total healthcare costs globally. In developed nations this proportion exceeds 4 % of healthcare costs. […] In the United States, the estimated cost of stroke in 2008 was $34.3 billion; this includes direct medical costs of $18.8 billion. […] United States data estimates the annual stroke incidence to be 795,000, of which approximately 610,000 are first-time strokes. […] In the United States, stroke as a cause of death declined by 19 % from 1998 to 2008 so that it is now the fourth most common cause of death.